-

Charlie Shreve Joins Shore Capital Partners as Principal

Shreve to Support Shore’s Healthcare Investment Strategy

CHICAGO--(BUSINESS WIRE)--Shore Capital Partners, (“Shore” or “the firm”), a strategic private equity firm focused on microcap investing in the healthcare, food and beverage, business services and real estate industries, with offices in Chicago and Nashville, today announced Charlie Shreve has joined the firm as Principal. In his role, Shreve will source, evaluate and enable the growth of Shore investments in the healthcare industry.

“We are excited to welcome Charlie to Shore,” said Justin Ishbia, Managing Partner. “Charlie’s experience as an operator as well as an investor will be an asset to our current and future portfolio companies. On the heels of the recent close of our latest healthcare fund, we are proud to be bringing exceptional talent like Charlie on board to continue executing our strategy.”

Prior to joining Shore, Shreve led business development and strategy at EyeSouth Partners, an ophthalmology-focused Shore portfolio company. At EyeSouth, Shreve oversaw growth efforts to expand the network to over 25 practices, 210 physicians and 115 clinical and surgical locations.

“I am excited to join the Shore team and support the firm’s commitment to invest and partner with quality microcap companies in the healthcare sector,” said Shreve. “I have seen first-hand how Shore’s experienced team and differentiated model leads to incredible growth for its portfolio companies, and I look forward to helping more healthcare organizations flourish.”

Previously, Shreve worked at Keystone Capital as an investment professional and Jefferies as an investment banker. Shreve received his B.S. in Finance from the University of Kansas.

About Shore Capital Partners

Shore Capital, a Chicago-based private equity firm with offices in Nashville, is focused on microcap investments within the Healthcare, Food and Beverage, Business Services, and Real Estate industries. Shore supports management partners with capital, business development expertise, and industry knowledge to accelerate growth, fund acquisitions, and generate value for shareholders. Shore targets investments in proven, successful private companies with superior management teams, stable cash flow, and significant growth potential, including organic growth and growth through industry consolidation. Shore has $2 billion of equity capital under management through various investment vehicles. For more information, please visit: www.shorecp.com.

Contacts

Jordan Niezelski
jordan.niezelski@edelman.com
(860) 833 - 2947

Shore Capital Partners


Release Versions

Contacts

Jordan Niezelski
jordan.niezelski@edelman.com
(860) 833 - 2947

More News From Shore Capital Partners

Reliant Infusion Names Tommy Pourmahram Chief Executive Officer

CHICAGO--(BUSINESS WIRE)--Shore Capital Partners ("Shore" or "Shore Capital"), a Chicago-based private equity firm with an office in Nashville, today announced that Tommy Pourmahram has been named Chief Executive Officer of Reliant Infusion, a Shore portfolio company and provider of specialty infusion services. Pourmahram brings more than 20 years of healthcare leadership to the role, most recently in senior executive positions at McKesson's Oncology & Multispecialty Segment. McKesson is a...

ONDEX Automation Acquires ROI Engineering, Expanding Process Controls Capabilities to the West Coast

CHICAGO--(BUSINESS WIRE)--ONDEX Automation today announced the acquisition of ROI Engineering, a control systems integrator based in Laguna Hills, California. This is ONDEX's seventh acquisition since April 2024 and expands the company's process controls capabilities while establishing a West Coast presence to better serve customers across the western United States. Founded in 2002, ROI Engineering provides control system integration, engineering, consulting, and technical services across a ran...

Shore Capital Partners Announces Sale of Shore Capital Real Estate Partners Fund I Portfolio to Four Corners Property Trust

CHICAGO--(BUSINESS WIRE)--Shore Capital Partners (“Shore” or “Shore Capital”), a Chicago-based private equity firm with offices in Nashville, today announced the sale of the real estate portfolio held by Shore Capital Real Estate Partners Fund I to Four Corners Property Trust (NYSE: FCPT). The portfolio includes 102 Mission Pet Health (“MPH”) veterinary properties for a purchase price of approximately $268 million. Veterinary operations are not part of the transaction, and MPH, one of the nation...
Back to Newsroom